UnitedHealth posted a better-than-expected profit in the final quarter of 2024, but a nagging rise in medical costs and care utilization surprised Wall Street.
Shares of the health care giant slid Thursday after it released its first financial report since the brazen shooting of one of its executives outside a New York City hotel touched a national nerve and brought to the surface American frustration over health care access.
UnitedHealth leaders opened a call with analysts Thursday by offering thanks for condolences the company has received since the Dec. 4 death of Brian Thompson, CEO of the company's UnitedHealthcare business.
''Brian helped build this company and forged deep, trusted relationships for over 20 years, and the positive impact he had on people will be felt for years to come,'' Chief Financial Officer John Rex said.
In the recently concluded fourth quarter, more than 87% of the premiums UnitedHealth collected went back out the door to cover medical costs. That was ''well above'' what analysts expected, TD Cowen analyst Ryan Langston said in a research note.
UnitedHealth said it was still dealing with an increase in prescriptions for expensive specialty drugs, rate cuts to its federally funded Medicare business and other cost pressures it detailed in previous quarters.
The company's enrollment in the state and federally funded Medicaid programs dropped by about 400,000 people. UnitedHealth leaders said rate updates from states to cover costs from those remaining have lagged.
UnitedHealth's adjusted results, which exclude one-time items, totaled $6.81 per share in the quarter. The company's revenue climbed about 7% to $100.8 billion, which missed expectations.